Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy [Phase 4]
Phase 4 trial comparing indobufen vs aspirin for patients on dual antiplatelet therapy in coronary artery disease and gastroesophageal reflu…
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD) [Phase 2]
Phase 2 trial evaluating IW-3718 in patients with symptomatic gastroesophageal reflux disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Effective Mechanisms of Wu-Chu-Yu Tang on Gastroesophageal Disorder [Phase 4]
Phase 4 clinical trial update evaluating Wu-Chu-Yu Tang for gastroesophageal reflux disorder is in early or unknown status.
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: Role of Pepsin Assay in Wheezy Infants [Phase 4]
A Phase 4 clinical trial assessing the role of a pepsin assay in wheezy infants with gastroesophageal reflux disease has completed with post…
-
FDA approval · 2019-09-26FDA Approved: OMEPRAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic omeprazole in an Original Abbreviated New Drug Application, authorizing its use for the same in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-09-24FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for OMEPRAZOLE AND SODIUM BICARBONATE (omeprazole and sodium bicarbonate) from Oceanside Pharmaceuti…
-
FDA approval · 2019-09-16FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for pantoprazole sodium from Amneal Pharmaceuticals LLC.
-
FDA approval · 2019-09-11FDA Approved: ZANTAC 360 — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for ZANTAC 360 (famotidine) from Chattem, Inc., updating the product under an approved supplemen…
-
FDA approval · 2019-08-19FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Pantoprazole Sodium as an original generic application from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2019-08-07FDA Approved: RANITIDINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for ranitidine submitted by Rising Pharma Holdings, Inc., indicating an approved change to the p…
-
CLINICAL_TRIALS research · 2019-08-05Clinical Trial Update: Complications, Outcomes and Revisions Following Hiatal Hernia Repair With MIROMESH
Clinical trial completed assessing complications, outcomes, and revisions after hiatal hernia repair using MIROMESH.
-
CLINICAL_TRIALS trial_result · 2019-08-05Clinical Trial Update: PK Study With Pantoprazole in Obese Children and Adolescents [Phase 1]
Phase 1 PK study of pantoprazole in obese children and adolescents with gastroesophageal reflux disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD [Phase 4]
Phase IV study evaluating the impact of dietary fibers on symptoms and esophageal motility in non-erosive GERD has completed with posted res…
-
CLINICAL_TRIALS research · 2019-07-31Clinical Trial Update: Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance [Phase 4]
Phase 4 clinical trial update assessing applications and performance of the Bravo pH Monitoring System for gastroesophageal reflux disease.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Cytosponge Adequacy Study Evaluation II [NA]
Clinical trial update for Cytosponge Adequacy Study Evaluation II has completed with posted results.
-
FDA approval · 2019-07-16FDA Approved: METOCLOPRAMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for metoclopramide, a generic, indicating an updated or additional labeling under an approved A…
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of dexlansoprazole for heartburn relief in Chinese patients.
-
FDA approval · 2019-07-01FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for lansoprazole from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA process.
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Impact of Head of Bed Elevation in Symptoms of Patients With Gastroesophageal Reflux Disease [NA]
Clinical trial update on the effect of head-of-bed elevation on symptoms in patients with gastroesophageal reflux disease; study completed w…
-
FDA approval · 2019-06-11FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
The FDA approved a supplemental application for PEPCID COMPLETE, a chewable tablet combining famotidine with calcium carbonate and magnesium…
-
FDA approval · 2019-05-24FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for metoclopramide hydrochloride, authorizing an updated approval for this …
-
FDA approval · 2019-05-22FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for esomeprazole magnesium from Zydus Pharmaceuticals USA Inc., a generic proton pump inhibitor for acid-rela…
-
FDA approval · 2019-05-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original generic application for esomeprazole magnesium, authorizing its use as a proton pump inhibitor. The pro…
-
FDA approval · 2019-05-10FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
The FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd., approving the generic product update.
-
FDA approval · 2019-05-03FDA Approved: OMEPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for omeprazole from Aurobindo Pharma Limited under ANDA203270.